{
    "clinical_study": {
        "@rank": "153094", 
        "arm_group": {
            "arm_group_label": "epiretinal membrane", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Fovea is characterized by its vessel-free zone, called foveal avascular zone and it can be\n      visualized by fluorescein angiography. Removal of epiretinal membrane and internal limiting\n      membrane is frequently performed procedure and we suspected that these procedures may affect\n      integrity of foveal avascular zone.\n\n      The purpose of the present study is to evaluate the change of foveal avascular zone after\n      removal of epiretinal membrane and internal limiting membrane"
        }, 
        "brief_title": "Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Epiretinal Membrane", 
        "condition_browse": {
            "mesh_term": "Epiretinal Membrane"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  epiretinal membrane\n\n        Exclusion Criteria:\n\n          -  history of vitrectomy, intraocular surgery\n\n          -  any macular disease other than epiretinal membrane\n\n          -  media opacity obscuring the image of fluorescein angiography"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985490", 
            "org_study_id": "2013-07-163"
        }, 
        "intervention": {
            "arm_group_label": "epiretinal membrane", 
            "description": "fluorescein angiography is performed before, 1 week, 3months and 6months after the epiretinal membrane and internal limiting membrane removal.", 
            "intervention_name": "epiretinal membrane and internal limiting membrane removal", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "epiretinal membrane", 
            "foveal avascular zone", 
            "internal limiting membrane"
        ], 
        "lastchanged_date": "November 25, 2013", 
        "location": {
            "contact": {
                "email": "swkang@skku.edu", 
                "last_name": "Se Woong Kang, MD", 
                "phone": "82-2-3410-3562"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Samsung Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Se Woong Kang, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ga Eun Cho, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "swkang@skku.edu", 
            "last_name": "Se Woong Kang, MD", 
            "phone": "82-2-3410-3562"
        }, 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Se Woong Kang, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the change in area of foveal avascular zone at postoperative 6 months", 
            "measure": "area of foveal avascular zone", 
            "safety_issue": "No", 
            "time_frame": "postoperative 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985490"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "change in visual acuity", 
                "safety_issue": "No", 
                "time_frame": "postoperative 6 months"
            }, 
            {
                "measure": "change in macular thickness", 
                "safety_issue": "No", 
                "time_frame": "at 6 months"
            }, 
            {
                "measure": "change in metamorphopsia", 
                "safety_issue": "No", 
                "time_frame": "postoperative 6 months"
            }
        ], 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}